Depression and Anxiety Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with depression, confirmed through a specific structured interview called the Mini International Neuropsychiatric Interview (M.I.N.I.)
- People whose depression symptom score on the MADRS-S scale is 20 or higher, indicating at least moderate depression
- People whose depression medication has not changed in the past month
- People whose psychological treatment (such as therapy) has not changed in the past month
- People who have been admitted to a psychiatric ward in the past month
- People who have not had ECT (electroconvulsive therapy) or TMS (transcranial magnetic stimulation) in the past six months
- People who have signed an informed consent form agreeing to take part
- People for whom TMS treatment for depression has been considered appropriate by their doctor
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with an addiction to illicit drugs or alcohol
- People who are pregnant
- People who have epilepsy
- People who have metal implants in their head or within 30 cm of where the treatment device would be placed
- People who have an implanted medical device that responds to or is controlled by body signals (confirm with trial site)
- People who have an implanted medication pump
- People who have or have had intracardiac lines (wires previously placed near or in the heart), even if already removed
- People who regularly use benzodiazepines (a type of sedative or anti-anxiety medication)
- People with any condition that would make it significantly difficult to follow the trial requirements or stay involved throughout the study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melker Hagsäter, MD, MSc, PhD, Västra Götaland Regional Council
Phone: +46 3039 8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in MADRS-S from baseline to three weeks after first iTBS treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.